Literature DB >> 9832264

Repeated epidemics caused by extended-spectrum beta-lactamase-producing Serratia marcescens strains.

F Luzzaro1, M Perilli, R Migliavacca, G Lombardi, P Micheletti, A Agodi, S Stefani, G Amicosante, L Pagani.   

Abstract

An outbreak of Serratia marcescens involving 42 patients admitted to the general intensive care unit of the Hospital of Varese, Italy, occurred from March 1994 to August 1995. The causative strains were resistant to oxyimino-cephalosporins and monobactams due to their production of an extended-spectrum beta-lactamase. Another outbreak caused by Serratia marcescens strains had occurred in the same unit a few months earlier, from February to October 1993, with the strains involved producing a novel TEM-derived extended-spectrum beta-lactamase. In order to verify whether there were any relationships between isolates from the two epidemics, the strains and their enzymes were characterized. Biochemical data and gene amplification experiments showed that the isolates of the second outbreak harbored a non-conjugative plasmid of approximately 48 kb, codifying for the production of an SHV-derived extended-spectrum beta-lactamase with pI 8.2. Restriction fragment length polymorphism analysis of total genomic DNA by pulsed-field gel electrophoresis of Serratia marcescens isolates unambiguously identified two different bacterial clones responsible for the two epidemics. Epidemiological and microbiological investigations demonstrated the long persistence of Serratia marcescens strains and their circulation in other hospital wards, thus suggesting their possible role as a long-term reservoir for further epidemic spread.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832264     DOI: 10.1007/bf01708345

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Rapid plasmid DNA isolation from mucoid gram-negative bacteria.

Authors:  P Domenico; J L Marx; P E Schoch; B A Cunha
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio.

Authors:  K S Thomson; C C Sanders; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

8.  Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.

Authors:  D Gianneli; E Tzelepi; L S Tzouvelekis; A F Mentis; C Nikolopoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

9.  Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

Authors:  N A Curtis; R L Eisenstadt; C Rudd; A J White
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

Review 10.  beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact.

Authors:  C C Sanders; W E Sanders
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

View more
  8 in total

1.  Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors:  T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.

Authors:  Maurizio Sanguinetti; Brunella Posteraro; Teresa Spanu; Daniela Ciccaglione; Lucio Romano; Barbara Fiori; Giuseppe Nicoletti; Stefania Zanetti; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 3.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.

Authors:  Rafael Cantón; Antonio Oliver; Teresa M Coque; María del Carmen Varela; José Claudio Pérez-Díaz; Fernando Baquero
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens.

Authors:  Kent B Marty; Christopher L Williams; Linda J Guynn; Michael J Benedik; Steven R Blanke
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Authors:  Lukasz Naumiuk; Anna Baraniak; Marek Gniadkowski; Beata Krawczyk; Bartosz Rybak; Ewa Sadowy; Alfred Samet; Józef Kur
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens.

Authors:  Lin-Hui Su; Jonathan T Ou; Hsieh-Shong Leu; Ping-Cherng Chiang; Yueh-Pi Chiu; Ju-Hsin Chia; An-Jing Kuo; Cheng-Hsun Chiu; Chishih Chu; Tsu-Lan Wu; Chien-Feng Sun; Thomas V Riley; Barbara J Chang
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

8.  Risk factors for mortality in patients with Serratia marcescens bacteremia.

Authors:  Sun Bean Kim; Yong Duk Jeon; Jung Ho Kim; Jae Kyoung Kim; Hea Won Ann; Heun Choi; Min Hyung Kim; Je Eun Song; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.